Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Not yet recruiting 2Unknown 1

Sponsor Class

INDUSTRY 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 35Recurrence 27Multiple Myeloma 27Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma, Non-Hodgkin 25Lymphoma 20Neoplasms 16Lymphoma, Large B-Cell, Diffuse 16Lymphoma, B-Cell 15Lymphoma, Follicular 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Mantle-Cell 13Leukemia 13Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 11Ovarian Neoplasms 9Pancreatic Neoplasms 8Neoplasm Metastasis 8Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Head and Neck Neoplasms 7Carcinoma, Renal Cell 7Uterine Cervical Neoplasms 6Myelodysplastic Syndromes 6Melanoma 6Lymphoma, B-Cell, Marginal Zone 6Breast Neoplasms 6Liposarcoma, Myxoid 5Colorectal Neoplasms 5Burkitt Lymphoma 5

Interventions

pembrolizumab 7fludarabine 3Cyclophosphamide 3motexafin gadolinium 1fludarabine phosphate 1durvalumab 1Taxes 1Pemetrexed 1Paclitaxel 1Nivolumab 1MEDI0457 1Drug Therapy 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Oropharyngeal Neoplasms × fludarabine × Clear all
NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

SCG Cell Therapy Pte. Ltd.

Phase 1/2 Not yet recruiting
66 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05787535 2024-02-02

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

HRYZ Biotech Co.

Phase 1 Unknown
17 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05582590 2024-01-16

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

NexImmune Inc.

Phase 1 Not yet recruiting
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡